Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology

被引:20
|
作者
Jatana, Kris R. [1 ,2 ]
Balasubramanian, Priya [3 ]
McMullen, Kyle P. [2 ]
Lang, Jas C. [2 ]
Teknos, Theodoros N. [2 ]
Chalmers, Jeffrey J. [3 ]
机构
[1] Nationwide Childrens Hosp, Dept Pediat Otolaryngol Head & Neck Surg, Columbus, OH USA
[2] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA
基金
美国国家科学基金会;
关键词
circulating tumor cell; squamous cell carcinoma; surgery; immunomagnetic separation; EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; BONE-MARROW; CANCER PATIENTS; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; PERIPHERAL-BLOOD; BREAST-CANCER; DISSEMINATION; RISK;
D O I
10.1002/hed.24519
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to investigate the impact of surgical intervention on detection of circulating tumor cells (CTCs) in patients with squamous cell carcinoma of the head and neck (SCCHN.) Methods. We utilized a negative depletion technique to identify cytokeratin (CK)-positive CTCs. The numbers of CTCs immediately before and after surgical resection were compared. Results. Seventy-six blood samples from 38 patients with SCCHN were examined. Seventy-nine percent of the patients had CTCs detected before and after surgery. A total of 7.89% had no CTCs before surgery, yet had CTCs identified after surgery. Overall, 60.5% of patients had an increased number of CTCs/mL after surgery with a mean increase of 6.63-fold. A statistically significant increase in CTCs was seen after surgery (p = .02). Conclusion. The timing of sample collection in patients with SCCHN who have surgical intervention can potentially impact the number of CTCs identified. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1799 / 1803
页数:5
相关论文
共 50 条
  • [31] Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
    Mito, Ikko
    Takahashi, Hideyuki
    Kawabata-Iwakawa, Reika
    Ida, Shota
    Tada, Hiroe
    Chikamatsu, Kazuaki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
    Ikko Mito
    Hideyuki Takahashi
    Reika Kawabata-Iwakawa
    Shota Ida
    Hiroe Tada
    Kazuaki Chikamatsu
    Scientific Reports, 11
  • [33] Significance of Circulating Tumor Cells (CTCs) detection using the CellSearch system in patients with locally advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
    Bozec, A.
    Ilie, M.
    Long, E.
    Dassonville, O.
    Poissonnet, G.
    Santini, J.
    Chamorey, E.
    Peyrade, F.
    Benezery, K.
    Sudaka, A.
    Selva, E.
    Hofman, P.
    VIRCHOWS ARCHIV, 2012, 461 : S28 - S28
  • [34] Clinical Impact of Screening for Head and Neck Region and Intervention for Early Head and Neck Squamous Cell Carcinoma in Patients With Esophageal Squamous Cell Carcinoma
    Morimoto, Hiroyuki
    Yano, Tomonori
    Yoda, Yusuke
    Satake, Hironaga
    Yagishita, Atsushi
    Kojima, Takashi
    Oono, Yasuhiro
    Ikematsu, Hiroaki
    Kaneko, Kazuhiro
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 468 - 469
  • [35] Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
    Zhendan Wang
    Kai Cui
    Yan Xue
    Feng Tong
    Sheng Li
    Medical Oncology, 2015, 32
  • [36] Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
    Wang, Zhendan
    Cui, Kai
    Xue, Yan
    Tong, Feng
    Li, Sheng
    MEDICAL ONCOLOGY, 2015, 32 (05)
  • [37] Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
    Strati, A.
    Koutsodontis, G.
    Papaxoinis, G.
    Angelidis, I.
    Zavridou, M.
    Economopoulou, P.
    Kotsantis, I.
    Avgeris, M.
    Mazel, M.
    Perisanidis, C.
    Sasaki, C.
    Alix-Panabieres, C.
    Lianidou, E.
    Psyrri, A.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1923 - 1933
  • [38] CIRCULATING TUMOR CELLS MAY KAM WELL BE A PROGNOSTIC MARKER IN THE CLINICAL MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS
    Cox, Stephen
    Carter, Eric
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2021, 21 (04)
  • [39] Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma
    Chikamatsu, Kazuaki
    Tada, Hiroe
    Takahashi, Hideyuki
    Kuwabara-Yokobori, Yuki
    Ishii, Hiroki
    Ida, Shota
    Shino, Masato
    ORAL ONCOLOGY, 2019, 89 : 34 - 39
  • [40] PD-L1 expressing circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC)
    Strati, Areti
    Koutsodontis, George
    Angelidis, Was
    Sasaki, Clarence
    Avgeris, Margaritis
    Psyrri, Amanda
    Lianidou, Evi S.
    CANCER RESEARCH, 2016, 76